Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2012
03/13/2012US8133502 System for delivering a composition to the nasal membrane and method of using same
03/13/2012US8133494 Expression cassettes endcoding HIV-1 south african subtype C modified ENV proteins with deletions in V1 and V2
03/13/2012US8133485 Immunoglobulin specifi for mast cell immunoglobulin receptor (IRp60) for use in treatment and prevention of allergic disorders
03/13/2012CA2671634C Ejection liquid and ejection method
03/13/2012CA2660842C Polyconjugates for in vivo delivery of polynucleotides
03/13/2012CA2586871C Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
03/13/2012CA2549824C Use of 4-hydroxytamoxifen for the preparation of a medicament for the treatment of gynecomastia
03/13/2012CA2525615C Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine
03/13/2012CA2513595C Thin aqueous cataplasm
03/13/2012CA2513144C Phospholipid derivative and method for producing the same
03/13/2012CA2511995C Pharmaceutical preparations for treatments of diseases and disorders of the breast
03/13/2012CA2497206C Thickener compositions comprising sclerotium gum and a copolymer
03/13/2012CA2487648C Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
03/13/2012CA2474216C Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
03/13/2012CA2463358C Prolonged release biodegradable microspheres and method for preparing same
03/13/2012CA2455406C Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
03/13/2012CA2442854C Hsa-free formulations of interferon-beta
03/13/2012CA2402191C Use of insulin for the treatment of cartilagenous disorders
03/13/2012CA2256308C Antibodies to the ed-b domain of fibronectin, their construction and uses
03/08/2012WO2012031250A2 Compositions for labeling nerves and methods of use
03/08/2012WO2012031205A2 Lipid-polymer hybrid particles
03/08/2012WO2012031164A2 Drug delivery by carbon nanotube arrays
03/08/2012WO2012031045A2 Phosphonate ester derivatives and methods of synthesis thereof
03/08/2012WO2012030745A1 MULTIVITAMIN TARGETING OF RNAi THERAPEUTICS
03/08/2012WO2012029913A1 Oral preparation
03/08/2012WO2012029870A1 Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient
03/08/2012WO2012029838A1 Orally disintegrating tablet
03/08/2012WO2012029827A1 Process for producing drug—block-copolymer composite and pharmaceutical product containing same
03/08/2012WO2012029820A1 Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
03/08/2012WO2012029456A1 Oil-in-water emulsion composition containing poorly-soluble drug, and method for manufacturing same
03/08/2012WO2012029348A1 Granules containing bitter drug and orally disintegrating tablet
03/08/2012WO2012029325A1 Percutaneous absorbent and adhesive sheet for skin patch
03/08/2012WO2012029160A1 Stabilized polyphenol solution and method for stabilizing polyphenol solution
03/08/2012WO2012029148A1 Freeze-dried recombinant human bone morphogenetic protein-2 preparation
03/08/2012WO2012029127A1 Skin patch sheet, utilization of same, and method for applying skin patch sheet
03/08/2012WO2012029097A1 Transdermal preparation
03/08/2012WO2012028733A1 A water-in-oil type emulsion for treating a disease of the eye
03/08/2012WO2012028340A1 Preventive ointment for diabetic foot
03/08/2012WO2012028319A1 Tamper resistant dosage form comprising inorganic salt
03/08/2012WO2012028315A1 A stabilizer for the preparation of a dry polio injectable vaccine composition
03/08/2012WO2012028311A1 Compositions comprising a taxane for coating medical devices
03/08/2012WO2012028101A1 Liquid compositions of insoluble drugs and preparation methods thereof
03/08/2012WO2012028056A1 A clinical preparation of scutellarin and the preparation method thereof
03/08/2012WO2012027797A1 Anti-inflammatory compostion
03/08/2012WO2012007623A3 Oligonucleotide-activated controlled-release system
03/08/2012WO2012007324A3 Stabilized factor viii variants
03/08/2012WO2011162421A3 Foam-type external skin preparation
03/08/2012WO2011157741A3 Human antibody drug conjugates against tissue factor
03/08/2012WO2011152652A3 Aceclofenac slow-release preparation providing an optimum pharmacological clinical effect when administered once a day
03/08/2012WO2011146518A3 Pegylated c-peptide
03/08/2012WO2011139103A3 Method for producing a water-insoluble gel composition and a water-insoluble gel produced thereby
03/08/2012WO2011122923A3 Long-acting interferon beta formulation using immunoglobulin fragment
03/08/2012WO2011122922A3 Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragment
03/08/2012WO2011122921A3 An insulin conjugate using an immunoglobulin fragment
03/08/2012WO2011090349A9 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties
03/08/2012WO2001000832A9 Methods for making apo-2 ligand using divalent metal ions
03/08/2012US20120059462 Methods for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
03/08/2012US20120059071 High-Purity Mogrosides And Process For Their Purification
03/08/2012US20120059070 Powderous formulations of fat-soluble active ingredients
03/08/2012US20120059069 Amphiphilic branched copolymer, methods of preparation, emulsions, and uses
03/08/2012US20120059068 Composition Based On Zeolite And Usage As Lick Stone
03/08/2012US20120058981 Androgen pharmaceutical composition and method for treating depression
03/08/2012US20120058975 Phosphonate Compounds
03/08/2012US20120058962 Buccal and/or sublingual therapeutic formulation
03/08/2012US20120058943 Bioactive Hydrogel
03/08/2012US20120058453 Hot melt dental materials and devices and methods for using the same
03/08/2012US20120058194 Pharmaceutical formulations comprising substituted benzimidazole derivatives
03/08/2012US20120058193 Injectable smart gel and method for fabricating the same
03/08/2012US20120058163 Water-dispersible and multicomponent fibers from sulfopolyesters
03/08/2012US20120058160 Particulate materials
03/08/2012US20120058158 Sublingual Pharmaceutical Composition Comprising a Neutral Oil
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012US20120058083 Therapies for Chronic Inflammatory Demyelinating Polyneuropathy Using Interferon-Beta
03/08/2012US20120058066 Self-assembling peptide and peptide gel with high strength
03/08/2012US20120058062 Two component interactive emulsion product
03/08/2012US20120058050 Loaded latex optical molecular imaging probes containing lipophilic large stokes shift dyes
03/08/2012US20120055780 Polysaccharide pseudo-sponge
03/08/2012CA2810217A1 Anti-cxcl13 antibodies and methods of using the same
03/08/2012CA2809934A1 Process for producing drug-block copolymer composite and pharmaceutical preparation containing same
03/08/2012CA2809835A1 Hemostatic compositions and methods of making and using same
03/08/2012CA2809679A1 Phosphonate ester derivatives and methods of synthesis thereof
03/08/2012CA2809617A1 Nanoparticle-based tumor-targeted drug delivery
03/08/2012CA2809460A1 A water-in-oil type emulsion for treating a disease of the eye
03/08/2012CA2808219A1 Tamper resistant dosage form comprising inorganic salt
03/08/2012CA2807433A1 Method for producing a lipid particle, the lipid particle itself and its use
03/08/2012CA2803052A1 Coating agent for pharmaceutical solid preparation, pharmaceutical film formulation, and coated pharmaceutical solid preparation
03/07/2012EP2425860A1 Modified Fc molecules
03/07/2012EP2425859A1 Olmesartan formulations
03/07/2012EP2425843A1 Dentine calcification agent and method for producing same
03/07/2012EP2425842A1 Composition for symptomatic local treatment of the nasal mucous membrane and nose drops containing this composition
03/07/2012EP2425829A1 Soluble pharmaceutical forms of n,n'-diaminodiphenyl sulphone for optimum use in the treatment of various diseases
03/07/2012EP2425827A1 Transdermal preparation
03/07/2012EP2425825A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425824A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425823A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425821A1 Pharmaceutical preparation containing oxycodone and naloxone
03/07/2012EP2425817A1 Polymerized micelles for diagnosis
03/07/2012EP2425816A2 A pharmaceutical composition for use in treating an ocular disease or condition and a method for producing the composition
03/07/2012EP2425815A1 Stabilized pharmaceutical sub-micron suspensions and methods of forming same
03/07/2012EP2425814A1 A water-in-oil type emulsion for treating a disease of the eye
1 ... 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 ... 1712